• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗B族链球菌天然III型多糖抗体在婴儿感染中的作用。

Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection.

作者信息

Baker C J, Edwards M S, Kasper D L

出版信息

Pediatrics. 1981 Oct;68(4):544-9.

PMID:7033911
Abstract

The role of maternally acquired antibody to native type III polysaccharide of group B Streptococcus as a determinant of susceptibility for infant systemic infection was investigated. Sera from 111 acutely ill infants with type III group B streptococcal bacteremia and/or meningitis and their mothers, and cord sera from 45 healthy neonates and their mothers who had type III group B streptococcal vaginal colonization at delivery were studied. Sera from each of 111 acutely ill infants contained very low levels of antibody (less than 1.7 microgram/ml, median 0.4 microgram/ml), and a significant correlation with maternal levels was tested for early onset infection (median 0.6 microgram/ml; 4 = .76; P less than .01). Women whose infants remained well had antibody levels greater than 2 microgram/ml in their sera (73%) more often than those whose infants developed symptomatic infection (17%) (P less than .001), and the median level in their sera (12.6 microgram/ml) was considerably higher. Study of sera obtained during convalescence from 86 surviving infants indicated a poor antibody response to infection. In contrast, high levels of antibody were detected in sera from each of five convalescent women with postpartum bacteremia. These data extend earlier observations suggesting the correlation between low levels of type-specific antibody in serum and risk for systemic infection with type III strains of group B streptococci.

摘要

研究了母体获得的抗B族链球菌天然III型多糖抗体作为婴儿全身感染易感性决定因素的作用。对111名患有III型B族链球菌菌血症和/或脑膜炎的急性病婴儿及其母亲的血清,以及45名健康新生儿及其在分娩时阴道有III型B族链球菌定植的母亲的脐带血清进行了研究。111名急性病婴儿的血清中抗体水平都非常低(低于1.7微克/毫升,中位数为0.4微克/毫升),对早发型感染检测到其与母体抗体水平有显著相关性(中位数为0.6微克/毫升;r = 0.76;P < 0.01)。婴儿保持健康的女性血清中抗体水平高于2微克/毫升的比例(73%)高于其婴儿出现症状性感染的女性(17%)(P < 0.001),且她们血清中的中位数水平(12.6微克/毫升)要高得多。对86名存活婴儿恢复期获得的血清研究表明,感染后的抗体反应较差。相比之下,在五名产后菌血症恢复期女性的血清中均检测到高水平抗体。这些数据扩展了早期观察结果,提示血清中低水平的型特异性抗体与III型B族链球菌全身感染风险之间存在相关性。

相似文献

1
Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection.抗B族链球菌天然III型多糖抗体在婴儿感染中的作用。
Pediatrics. 1981 Oct;68(4):544-9.
2
Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus.B族链球菌III型菌株感染中荚膜多糖抗体的定量测定。
J Clin Invest. 1977 May;59(5):810-8. doi: 10.1172/JCI108703.
3
Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.母体抗体缺乏与新生儿B族链球菌感染易感性的相关性。
N Engl J Med. 1976 Apr 1;294(14):753-6. doi: 10.1056/NEJM197604012941404.
4
Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus.用B族链球菌多糖疫苗对孕妇进行免疫接种。
N Engl J Med. 1988 Nov 3;319(18):1180-5. doi: 10.1056/NEJM198811033191802.
5
The natural history of group B streptococcal colonization in the pregnant woman and her offspring. II. Determination of serum antibody to capsular polysaccharide from type III, group B Streptococcus.孕妇及其后代中B族链球菌定植的自然史。II. 抗III型B族链球菌荚膜多糖血清抗体的测定。
Am J Obstet Gynecol. 1980 May 1;137(1):39-42. doi: 10.1016/0002-9378(80)90383-x.
6
Immunological investigation of infants with septicemia or meningitis due to group B Streptococcus.对因B族链球菌感染导致败血症或脑膜炎的婴儿进行的免疫学调查。
J Infect Dis. 1977 Aug;136 Suppl:S98-104. doi: 10.1093/infdis/136.supplement.s98.
7
Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen.母亲抗Ⅲ型B族链球菌IgG抗体水平与新生儿抵御该病原体引起的早发型疾病的保护作用相关。
J Infect Dis. 2004 Sep 1;190(5):928-34. doi: 10.1086/422756. Epub 2004 Jul 28.
8
Response to type III polysaccharide in women whose infants have had invasive group B streptococcal infection.婴儿患有侵袭性B族链球菌感染的女性对III型多糖的反应。
N Engl J Med. 1990 Jun 28;322(26):1857-60. doi: 10.1056/NEJM199006283222606.
9
Chronic carrier state in mothers of infants with group B streptococcal infections.B族链球菌感染婴儿的母亲中的慢性携带者状态。
Obstet Gynecol. 1985 Jul;66(1):84-8.
10
Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study.保护新生儿免受Ia型B族链球菌引起的早发型疾病所需的母体抗体水平:一项多中心血清流行病学研究。
J Infect Dis. 2001 Oct 15;184(8):1022-8. doi: 10.1086/323350. Epub 2001 Aug 31.

引用本文的文献

1
Emerging infection: streptococcal toxic shock-like syndrome caused by group B Streptococcus (GBS), .新发感染:B族链球菌(GBS)引起的链球菌中毒性休克样综合征
Autops Case Rep. 2024 Jun 21;14:e2024497. doi: 10.4322/acr.2024.497. eCollection 2024.
2
Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study.研制孕妇侵袭性 B 群链球菌疾病的血清保护相关物:一项可行性研究。
Health Technol Assess. 2019 Dec;23(67):1-40. doi: 10.3310/hta23670.
3
Safety and Immunogenicity of a Second Dose of an Investigational Maternal Trivalent Group B Streptococcus Vaccine in Nonpregnant Women 4-6 Years After a First Dose: Results From a Phase 2 Trial.
研究性母体 B 群链球菌二价疫苗在首剂接种后 4-6 年对非孕妇的安全性和免疫原性:一项 2 期试验结果。
Clin Infect Dis. 2020 Jun 10;70(12):2570-2579. doi: 10.1093/cid/ciz737.
4
The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations.免疫保护相关因素在 B 型链球菌疫苗获得许可、政策决策和用于母亲免疫接种的路径中的作用:来自世界卫生组织磋商的考虑。
Vaccine. 2019 May 27;37(24):3190-3198. doi: 10.1016/j.vaccine.2019.04.039. Epub 2019 Apr 25.
5
Association between antibodies against group B Streptococcus surface proteins and recto-vaginal colonisation during pregnancy.抗 B 群链球菌表面蛋白抗体与孕期直肠-阴道定植的相关性。
Sci Rep. 2017 Nov 28;7(1):16454. doi: 10.1038/s41598-017-16757-9.
6
Role of HIV exposure and infection in relation to neonatal GBS disease and rectovaginal GBS carriage: a systematic review and meta-analysis.HIV 暴露和感染与新生儿 GBS 病和直肠阴道 GBS 携带的关系:系统评价和荟萃分析。
Sci Rep. 2017 Oct 23;7(1):13820. doi: 10.1038/s41598-017-13218-1.
7
Opsonophagocytic Antibodies to Serotype Ia, Ib, and III Group B Streptococcus among Korean Infants and in Intravenous Immunoglobulin Products.韩国婴儿及静脉注射免疫球蛋白产品中针对Ia、Ib和III型B族链球菌的调理吞噬抗体
J Korean Med Sci. 2017 May;32(5):737-743. doi: 10.3346/jkms.2017.32.5.737.
8
Neonatal Group B Streptococcal Disease in Otherwise Healthy Infants: Failure of Specific Neonatal Immune Responses.健康新生儿的B族链球菌病:特异性新生儿免疫反应的失效
Front Immunol. 2017 Mar 7;8:215. doi: 10.3389/fimmu.2017.00215. eCollection 2017.
9
Risk factors for group B streptococcal disease in neonates of mothers with negative antenatal testing.产前检查结果为阴性的母亲所生新生儿患B族链球菌病的危险因素。
J Perinatol. 2017 Feb;37(2):157-161. doi: 10.1038/jp.2016.201. Epub 2016 Nov 17.
10
Group B vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries.B组疫苗研发:现状与未来考量,重点关注低收入和中等收入国家的前景
F1000Res. 2016 Sep 22;5:2355. doi: 10.12688/f1000research.9363.1. eCollection 2016.